ARCHIVES

FDA Softening Its Stance On CME Guidelines; New Version To Be More In Line with ACCME

This article is from The Cancer Letter archive.

Vol. 18 No. 14 | April 3, 1992

Download PDF Visit The Full Archive

Related Articles

Anthrax Found At Local P.O.

November 2, 2001

Brigham & Women’s Suspends Controversial Morcellation Study As Apparent “Difference of Opinion” with FDA Comes to Light

November 26, 2014

NIH Acknowledges Role Of Pasteur Virus In AIDS Test, Gives France More Royalties

July 15, 1994

NCI “Can’t Justify Size Of Intramural Program”

May 12, 1995

Sloan-Kettering Sues Empire Blue Cross Over Reimbursement

September 17, 1993

Miami Radiotherapy Program Defended

June 30, 1978